Healthcare provider profile · identity verified

Christopher Smith, MD

Family Practice · ISHPEMING, MI · NPI 1598260259

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	787	222
Lisinopril	Lisinopril	526	140
Amlodipine Besylate	Amlodipine Besylate	410	107
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	322	44
Losartan Potassium	Losartan Potassium	316	82
Omeprazole	Omeprazole	269	74
Tamsulosin Hcl	Tamsulosin Hcl	223	64
Metoprolol Succinate	Metoprolol Succinate	212	66
Gabapentin	Gabapentin	199	31
Levothyroxine Sodium	Levothyroxine Sodium	194	56
Simvastatin	Simvastatin	189	46
Metformin Hcl	Metformin Hcl	181	55
Albuterol Sulfate Hfa	Albuterol Sulfate	169	50
Sertraline Hcl	Sertraline Hcl	158	38
Metoprolol Tartrate	Metoprolol Tartrate	145	39
Montelukast Sodium	Montelukast Sodium	131	33
Rosuvastatin Calcium	Rosuvastatin Calcium	130	42
Hydrochlorothiazide	Hydrochlorothiazide	129	36
Furosemide	Furosemide	115	44
Farxiga	Dapagliflozin Propanediol	103	25
Jardiance	Empagliflozin	100	25
Xarelto	Rivaroxaban	100	19
Eliquis	Apixaban	91	26
Famotidine	Famotidine	87	23
Pantoprazole Sodium	Pantoprazole Sodium	85	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	18
Allopurinol	Allopurinol	82	22
Meloxicam	Meloxicam	81	28
Trazodone Hcl	Trazodone Hcl	81	17
Spironolactone	Spironolactone	77	24
Carvedilol	Carvedilol	73	23
Fluticasone Propionate	Fluticasone Propionate	71	24
Escitalopram Oxalate	Escitalopram Oxalate	70	17
Amitriptyline Hcl	Amitriptyline Hcl	66	18
Oxycodone Hcl	Oxycodone Hcl	65	suppressed
Enalapril Maleate	Enalapril Maleate	64	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	14
Ozempic	Semaglutide	63	14
Lorazepam	Lorazepam	61	11
Potassium Chloride	Potassium Chloride	61	16
Prednisone	Prednisone	58	26
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Metformin Hcl Er	Metformin Hcl	57	14
Pravastatin Sodium	Pravastatin Sodium	53	14
Quetiapine Fumarate	Quetiapine Fumarate	52	13
Dicyclomine Hcl	Dicyclomine Hcl	49	suppressed
Alendronate Sodium	Alendronate Sodium	48	11
Alprazolam	Alprazolam	47	11
Esomeprazole Magnesium	Esomeprazole Magnesium	47	12
Januvia	Sitagliptin Phosphate	47	suppressed
Morphine Sulfate Er	Morphine Sulfate	47	suppressed
Spiriva Handihaler	Tiotropium Bromide	45	11
Tizanidine Hcl	Tizanidine Hcl	45	12
Duloxetine Hcl	Duloxetine Hcl	44	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	15
Warfarin Sodium	Warfarin Sodium	39	11
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	12
Pregabalin	Pregabalin	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Ondansetron Odt	Ondansetron	35	suppressed
Chlorthalidone	Chlorthalidone	34	13
Finasteride	Finasteride	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Bupropion Xl	Bupropion Hcl	33	11
Clonazepam	Clonazepam	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Atenolol	Atenolol	23	suppressed
Bumetanide	Bumetanide	23	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Oxycontin	Oxycodone Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Estradiol	Estradiol	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Glipizide	Glipizide	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Relistor	Methylnaltrexone Bromide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Theophylline Er	Theophylline Anhydrous	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Colchicine	Colchicine	11	suppressed
Diazepam	Diazepam	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nystatin	Nystatin	11	suppressed
Unifine Pentips	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error